[The clinico-immunological efficacy of triacort in bronchial asthma]. 1993

L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad

Efficacy of the home-made inhalant preparation "Tricort-aerosol" in 30 patients with moderate and severe bronchial asthma was assessed. Clinical, functional and immunological measures have been analyzed in the course of treatment with the drug. Administration of the drug in complex therapy was proved to be advisable in patients with different forms of bronchial asthma.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 1984, Sovetskaia meditsina,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 1985, Terapevticheskii arkhiv,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 1999, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 2001, Meditsina truda i promyshlennaia ekologiia,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 1990, Terapevticheskii arkhiv,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 1998, Likars'ka sprava,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
December 1966, Gaceta medica de Mexico,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
October 1975, Bollettino dell'Istituto sieroterapico milanese,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
January 1982, Panminerva medica,
L S Kogosova, and N N Kovalenko, and O V Strafun, and F I Novosad
September 1986, Indian pediatrics,
Copied contents to your clipboard!